Haisco Pharmaceutical Group Co., Ltd. (SHE: 002653)

Haisco Pharmaceutical Group Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	806.73	1,169	775.39	575.11	453.97	892.75
Short-Term Investments	-	-	-	-	410	330.47
Trading Asset Securities	480.16	160.06	-	-	370.32	-
Cash & Short-Term Investments	1,287	1,329	775.39	575.11	1,234	1,223
Cash Growth	46.01%	71.37%	34.82%	-53.41%	0.90%	22.52%
Accounts Receivable	1,166	883.9	803.79	569.97	487.61	540.06
Other Receivables	42.59	46.79	47.14	78.5	68.54	66.45
Receivables	1,209	930.69	850.93	648.47	556.16	606.5
Inventory	286.02	281.29	346	259.95	223.9	189.25
Other Current Assets	99.82	100.02	81.32	64.9	81.38	56.46
Total Current Assets	2,882	2,641	2,054	1,548	2,096	2,075
Property, Plant & Equipment	987.76	996.04	1,074	1,137	1,126	1,039
Long-Term Investments	195.97	232.46	422.17	381.19	398.83	455.85
Other Intangible Assets	1,260	751.23	708.33	682.47	599.98	320.85
Long-Term Deferred Tax Assets	136.22	148.24	126.08	83.57	80.6	146.6
Long-Term Deferred Charges	1,035	1,427	1,233	822.42	587.16	644.02
Other Long-Term Assets	413.36	457.37	430.15	350.51	108.15	353.8
Total Assets	6,910	6,653	6,048	5,005	4,997	5,035
Accounts Payable	172.18	208.99	242.44	301.4	419.95	615.79
Accrued Expenses	85.59	200.09	136.68	120.63	93.13	560.5
Short-Term Debt	237.11	99.98	484.69	452.18	740	650
Current Portion of Long-Term Debt	665.35	833.59	295.4	325.78	-	350.1
Current Portion of Leases	-	7.41	6.64	8	-	-
Current Income Taxes Payable	66.45	16.08	16.1	1.71	47.73	62
Current Unearned Revenue	27.35	14.61	26.96	28.44	26.02	54.11
Other Current Liabilities	195	123.23	279.64	279.98	389.4	204.02
Total Current Liabilities	1,449	1,504	1,489	1,518	1,716	2,497
Long-Term Debt	1,164	854.68	1,320	452.41	334.9	79.9
Long-Term Leases	6.74	10.85	4.52	10.91	-	-
Long-Term Unearned Revenue	105.6	108.47	98.52	102.54	87.14	77.93
Long-Term Deferred Tax Liabilities	3.45	4.01	2.53	1.11	1.33	1.57
Other Long-Term Liabilities	-	0.38	-	-	2.23	2.68
Total Liabilities	2,729	2,482	2,914	2,085	2,142	2,659
Common Stock	1,120	1,114	1,076	1,077	1,074	1,084
Additional Paid-In Capital	936.25	853.38	100.82	97.62	78.57	94.55
Retained Earnings	2,207	2,210	1,807	1,733	1,787	1,399
Treasury Stock	-90.03	-9.15	-24.44	-38.31	-24.76	-224.6
Comprehensive Income & Other	18.95	11.86	76.41	-26.82	-13.3	17.7
Total Common Equity	4,192	4,180	3,036	2,842	2,902	2,371
Minority Interest	-11.05	-9.36	97.68	78.27	-47.65	5.31
Shareholders' Equity	4,181	4,171	3,133	2,920	2,855	2,377
Total Liabilities & Equity	6,910	6,653	6,048	5,005	4,997	5,035
Total Debt	2,073	1,807	2,111	1,249	1,075	1,080
Net Cash (Debt)	-786.31	-477.74	-1,336	-674.16	159.39	143.22
Net Cash Growth	-	-	-	-	11.29%	125.99%
Net Cash Per Share	-0.71	-0.44	-1.25	-0.63	0.15	0.13
Filing Date Shares Outstanding	1,136	1,048	1,036	1,091	1,137	1,101
Total Common Shares Outstanding	1,136	1,048	1,036	1,091	1,137	1,101
Working Capital	1,433	1,137	565.09	30.32	379.5	-421.09
Book Value Per Share	3.69	3.99	2.93	2.61	2.55	2.15
Tangible Book Value	2,932	3,429	2,327	2,159	2,302	2,050
Tangible Book Value Per Share	2.58	3.27	2.25	1.98	2.03	1.86
Buildings	-	965.52	922.14	931.62	684.59	677.68
Machinery	-	748.62	709.94	677.15	602.24	564.48
Construction In Progress	-	5.87	97.9	88.54	335.2	228.81

Source: S&P Capital IQ. Standard template. Financial Sources.